Dolby Laboratories (DLB) Tops Q3 EPS by 7c ; Offers Guidance

Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.78, $0.07 better than the analyst estimate of $0.71. Revenue for the quarter came in at $316 million versus the consensus estimate of $305.23 million.

GUIDANCE:

Dolby Laboratories sees Q4 2025 EPS of $0.61-$0.76, versus the consensus of $0.77. Dolby Laboratories sees Q4 2025 revenue of $288-318 million, versus the consensus of $310.1 million.

Dolby Laboratories sees FY2025 EPS of $3.88-$4.03, versus the consensus of $3.97. Dolby Laboratories sees FY2025 revenue of $1.33-1.36 billion, versus the consensus of $1.34 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• FDA aligns with Regenxbio on path to refile MPS II gene therapy BLA
• Labcorp makes RNA-based colorectal cancer home test available nationwide